Lithium Ionic (LTH.V) is up 50% in 3 months, and is moving toward production
Digital Twinning, and how EdgeTI (CTRL.V) is a serious story you’ve never heard of
Bionxt Solutions (BNXT.C): Seeking to confirm national-level cancer drug patent
Why Prospera Energy (PEI.V) might be a transformational investment opportunity in Canadian oil & gas
Sparc AI (SPAI.C) completes development of drone advanced target acquisition system
Plurilock (PLUR.V) lands $19 million deal, largest in their history
Ben Lightburn, CEO, director and co-founder of Filament Health (FH.NEO), a Canadian-based psychedelics company focused on the natural extraction and clinical delivery of psilocybin compounds, faces off with Equity.Guru founder, Chris Parry, to answer some hard-hitting questions regarding the psychedelics sector and Filament’s future prospects.
Enjoy!
Filament Health (FH.NEO) – Investor Roundtable Video #7